We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INGR icon
651
Ingredion
INGR
$6.42B
$234K ﹤0.01%
+2,000
New +$225K
SU icon
652
Suncor Energy
SU
$77.7B
$228K ﹤0.01%
6,183
-320
-5% -$10.8K
AA icon
653
Alcoa
AA
$11.3B
– –
-24,790
Closed -$843K
ACHC icon
654
Acadia Healthcare
ACHC
$2.55B
– –
-11,019
Closed -$857K
ATKR icon
655
Atkore
ATKR
$2.41B
– –
-1,740
Closed -$278K
BDTX icon
656
Black Diamond Therapeutics
BDTX
$95.1M
– –
-540,009
Closed -$1.52M
BEAM icon
657
Beam Therapeutics
BEAM
$2.68B
– –
-212,665
Closed -$5.79M
BILL icon
658
BILL Holdings
BILL
$4.72B
– –
-3,640
Closed -$297K
BLDP
659
Ballard Power Systems
BLDP
$754M
– –
-161,449
Closed -$601K
COGT icon
660
Cogent Biosciences
COGT
$6.76B
– –
-232,487
Closed -$1.37M
CPNG icon
661
Coupang
CPNG
$27.2B
– –
-355,800
Closed -$5.76M
CVNA icon
662
Carvana
CVNA
$47.5B
– –
-19,065
Closed -$202K
DSGN icon
663
Design Therapeutics
DSGN
$751M
– –
-225,000
Closed -$596K
ESGR
664
DELISTED
Enstar Group
ESGR
– –
-1,056
Closed -$311K
EWC icon
665
iShares MSCI Canada ETF
EWC
$6.12B
– –
-60,700
Closed -$2.23M
GIB icon
666
CGI
GIB
$15.4B
– –
-2,642
Closed -$284K
GLUE icon
667
Monte Rosa Therapeutics
GLUE
$1.82B
– –
-135,000
Closed -$763K
HOG icon
668
Harley-Davidson
HOG
$2.61B
– –
-8,354
Closed -$308K
HRI icon
669
Herc Holdings
HRI
$4.78B
– –
-9,759
Closed -$1.45M
IRBT
670
DELISTED
iRobot
IRBT
– –
-13,094
Closed -$507K
KLG
671
DELISTED
WK Kellogg Co
KLG
– –
-26,225
Closed -$345K
KPTI icon
672
Karyopharm Therapeutics
KPTI
$155M
– –
-35,380
Closed -$459K
KRG icon
673
Kite Realty
KRG
$5.86B
– –
-20,359
Closed -$465K
KRYS icon
674
Krystal Biotech
KRYS
$10.7B
– –
-55,000
Closed -$6.82M
LCID icon
675
Lucid Motors
LCID
$3.11B
– –
-6,273
Closed -$264K
25 26
27
28 29

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.